Bayer anticipates a return to earnings growth in 2026. That prediction came after revenues dropped in 2025. Reuters says Bayer, which makes farming pesticides, says this year will be the most difficult in terms of financial performance, with net sales basically even with the prior year and a drop in earnings and free cash flow. “The company expects improved performance from 2026 onward,” says CEO Bill Anderson. He’s facing increasing pressure from investors to make good on restructuring efforts and turn around what’s predicted to be the third annual operating income drop in 2025. Beyond 2026, the company says it was aiming for an adjusted operating margin percentage in the mid-20s at its Crop Science division by 2029, up from 19.4 percent last year. Anderson is cutting managerial jobs, speeding up company decision-making, and slashing red tape. He reaffirmed delaying plans to break up Bayer’s diversified businesses for another two years.
Welcome
